BiotechTube
Home/Capricor Therapeutics/Frank Litvack, M.D., FACC
FL

Frank Litvack, M.D., FACC

Executive Chairman

Capricor Therapeutics

Therapeutic Areas

Rare DiseasesNeuromuscularCardiologyInfectious Disease

Capricor Therapeutics Pipeline

DrugIndicationPhase
Deramiocel (CAP-1002)Duchenne Muscular Dystrophy (DMD)Phase 3
StealthX™ VaccineCOVID-19 (Booster)Phase 1
StealthX™ TherapeuticsOncology & Other TargetsPreclinical

Leadership Team at Capricor Therapeutics

LM
Linda Marbán, Ph.D.
Chief Executive Officer and Director
MB
Michael Binks, M.D.
Chief Medical Officer
KA
Kristi A. H. Elliott, Ph.D.
Chief Operating & Science Officer
View full Capricor Therapeutics profile